Source: DGNews  |  Posted 8 years ago

First Long-Acting, Newer-Generation Antipsychotic Addresses Major Challenge of Schizophrenia Treatment

TITUSVILLE, NJ -- October 30, 2003 -- The U.S. Food and Drug Administration (FDA) has approved Risperdal